BindingDB logo
myBDB logout

BDBM284106 4-(6-(4-(3-fluoropiperidine-1- carbonyl)piperazin-1- yl)pyridin-3-yl)-6-(1-methyl- 1H-pyrazol-4-yl)pyrazolo[1,5- a]pyridine-3-carbonitrile::US10023570, Example 116::US10174027, Example 116

SMILES: Cn1cc(cn1)-c1cc(-c2ccc(nc2)N2CCN(CC2)C(=O)N2CCCC(F)C2)c2c(cnn2c1)C#N

InChI Key: InChIKey=YOPDHXKOVNCMPB-UHFFFAOYSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 284106   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
RET Kinase (aa 658-1114)


(Homo sapiens (Human))
BDBM284106
PNG
(4-(6-(4-(3-fluoropiperidine-1- carbonyl)piperazin-...)
Show SMILES Cn1cc(cn1)-c1cc(-c2ccc(nc2)N2CCN(CC2)C(=O)N2CCCC(F)C2)c2c(cnn2c1)C#N
Show InChI InChI=1S/C27H28FN9O/c1-33-16-22(15-31-33)20-11-24(26-21(12-29)14-32-37(26)17-20)19-4-5-25(30-13-19)34-7-9-35(10-8-34)27(38)36-6-2-3-23(28)18-36/h4-5,11,13-17,23H,2-3,6-10,18H2,1H3
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 11.7n/an/an/an/a7.4n/a



Array BioPharma Inc

US Patent


Assay Description
Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF® KinEASE -TK ...


US Patent US10023570 (2018)


BindingDB Entry DOI: 10.7270/Q2Q81G4V
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase receptor Ret


(Homo sapiens (Human))
BDBM284106
PNG
(4-(6-(4-(3-fluoropiperidine-1- carbonyl)piperazin-...)
Show SMILES Cn1cc(cn1)-c1cc(-c2ccc(nc2)N2CCN(CC2)C(=O)N2CCCC(F)C2)c2c(cnn2c1)C#N
Show InChI InChI=1S/C27H28FN9O/c1-33-16-22(15-31-33)20-11-24(26-21(12-29)14-32-37(26)17-20)19-4-5-25(30-13-19)34-7-9-35(10-8-34)27(38)36-6-2-3-23(28)18-36/h4-5,11,13-17,23H,2-3,6-10,18H2,1H3
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 11.7n/an/an/an/an/an/a



Array BioPharma Inc

US Patent


Assay Description
Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF® KinEASE¿-TK ...


US Patent US10174027 (2019)


BindingDB Entry DOI: 10.7270/Q2TH8PRD
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase receptor Ret


(Homo sapiens (Human))
BDBM284106
PNG
(4-(6-(4-(3-fluoropiperidine-1- carbonyl)piperazin-...)
Show SMILES Cn1cc(cn1)-c1cc(-c2ccc(nc2)N2CCN(CC2)C(=O)N2CCCC(F)C2)c2c(cnn2c1)C#N
Show InChI InChI=1S/C27H28FN9O/c1-33-16-22(15-31-33)20-11-24(26-21(12-29)14-32-37(26)17-20)19-4-5-25(30-13-19)34-7-9-35(10-8-34)27(38)36-6-2-3-23(28)18-36/h4-5,11,13-17,23H,2-3,6-10,18H2,1H3
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 11.7n/an/an/an/an/an/a



Array BioPharma Inc

US Patent


Assay Description
Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF® KinEASE-TK a...


US Patent US10174028 (2019)


BindingDB Entry DOI: 10.7270/Q2PR7Z2J
More data for this
Ligand-Target Pair